| REVIEW ARTICLE |
|
| Year : 2011 | Volume
: 15
| Issue : 5 | Page : 12-16 |
|
|
Degludec insulin: A novel basal insulin
Sanjay Kalra1, Ambika Gopalakrishnan Unnikrishnan2, Manash Baruah3, Bharti Kalra4
1 Department of Endocrinology, Bharti Hospital and BRIDE, Karnal, India
2 Department of Endocrinology, AIMS, Kochi, India
3 Department of Endocrinology, Excel Hospital, Guwahati, India
4 Department of Diabetology, Bharti Hospital and BRIDE, Karnal, India
Correspondence Address:
Sanjay Kalra
Department of Endocrinology, Bharti Hospital and BRIDE, Karnal
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2230-8210.83056
|
|
|
This paper reviews a novel insulin analogue, degludec, which has the potential to emerge as an ideal basal insulin. It reviews the limitations of existing basal insulin and analogues, and highlights the need for a newer molecule. The paper discusses the potential advantages of degludec, while reviewing its pharmacologic and clinical studies done so far. The paper assesses the potential role of insulin degludec and degludec plus in clinical diabetes practice. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
